MedPath

Individualized Bowel Preparation for Colonoscopy

Phase 4
Conditions
Colon Disease
Interventions
Drug: Standard Preparation
Drug: Individualized Preparation
Registration Number
NCT03428724
Lead Sponsor
Clinical Hospital Colentina
Brief Summary

A randomized control trial comparing a standard bowel preparation for colonoscopy with an individualized bowel preparation strategy based on patient characteristics

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
450
Inclusion Criteria
  • elective out-patient diagnostic or therapeutic colonoscopy
Exclusion Criteria
  • pregnant women; refusal to participate; significant comorbidities (ASA score 3 or above); suspicion of bowel perforation;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
standard groupStandard Preparationstandard polyethylene glycol preparation for colonoscopy
individualized groupIndividualized Preparationeither a low or a high volume bowel preparation according to patient characteristics
Primary Outcome Measures
NameTimeMethod
bowel preparation quality1-2 hours after completing bowel preparation

Boston bowel preparation score (BBPS)

Secondary Outcome Measures
NameTimeMethod
patient comfort during bowel preparation1-2 hours after completing bowel preparation

0-10 patient comfort score using a standard visual-analogue scale

Trial Locations

Locations (2)

Colentina Clinical Hospital

🇷🇴

Bucharest, Romania

Carol Davila Emergency Military Hospital

🇷🇴

Bucharest, Romania

© Copyright 2025. All Rights Reserved by MedPath